Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage
Launched by UNIVERSITY OF BARCELONA · Mar 27, 2020
Trial Information
Current as of August 27, 2025
Unknown status
Keywords
ClinConnect Summary
Location: This study is going to take place in the Dentistry Hospital of the University of Barcelona (Campus of Bellvitge).
Study subjects: The sample (105 patients) consists of patients with single tooth edentulous spaces or posterior maxillary and/or mandible edentulous spaces in need of dental implants with screw-retained single fixed crowns. All of them are being properly informed about the study according to the Comité Ético (CEIC) del Hospital Odontològic Universitat de Barcelona guidelines, and informed consent must be signed prior to the interventions.
Material: Registration paper...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects who accept signing voluntarily the informed consent before doing any action related to the study.
- • ≥18-years-old patients.
- • Edentulous single spaces or edentulous posterior maxilla or mandible (from the first premolar to the second molar) with screw-retained single fixed crowns.
- • Single implants successfully osseointegrated placed at least 16 weeks post-extraction.
- • O'Leary plaque index and or bleeding on probing ≤25%.
- • Dental implants with screwed-retained prosthesis.
- Exclusion Criteria:
- • Systemic diseases that can interfere dental implant placement.
- • Any contraindication for surgery procedures.
- • Heavy smokers (\> 20cig/day).
- • Background of drug abuse or other factors such as psychiatric diseases that, in opinion of the examiner, could interfere with the ability of the patient to cooperate and compliment with the study.
- • Patients who have had participated with another clinical trial the last 30 days.
- • Pregnant women or in lactation.
- • Patients with bad oral hygiene or not motivated.
- • Probing pockets depths with bleeding of ≥4 mm on a tooth adjacent to the edentulous space.
- • Guided bone regeneration required in the same time of the implant placement.
About University Of Barcelona
The University of Barcelona, a prestigious institution renowned for its commitment to research and academic excellence, serves as a leading sponsor for clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a rich history of innovation and collaboration, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research across various fields, including medicine, pharmacology, and public health. Through its robust network of partnerships with healthcare providers and research organizations, the University of Barcelona is dedicated to fostering advancements in clinical practice and contributing to the development of effective therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
L'hospitalet De Llobregat, Catalunya, Spain
Patients applied
Trial Officials
Rui Figueiredo, DDS, MS, PhD
Study Director
University of Barcelona
Eduard Valmaseda-Castellón, DDS, MS, PhD
Study Chair
University of Barcelona
Octavi Camps-Font, DDS, MS
Principal Investigator
University of Barcelona
Roxana Ghiorghiu, DDS, MS
Principal Investigator
University of Barcelona
Laura Rubianes-Porta, DDS, MS
Principal Investigator
University of Barcelona
Anna Piñol-Olea, DDS, MS
Principal Investigator
University of Barcelona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials